Advertisement
Новости Форекс
Dollar Loses Ground As Risk Sentiment Improves
The U.S. dollar turned in a weak performance on Monday as easing worries about global banking sector woes helped lift sentiment and prompted investors to seek risikier assets such as equities.
RTTNews |
884 дней спустя
Swiss Market Ends On Strong Note
The Switzerland stock market ended on a strong note on Monday, in line with markets across Europe, as concerns about global banking crisis eased thanks to some positive developments in the sector.
RTTNews
|
885 дней спустя
European Markets Close Higher Amid Easing Concerns Over Banking Sector Woes
European stocks closed higher on Monday amid easing concerns about the banking crisis following the latest developments in the sector.
RTTNews
|
885 дней спустя
Canadian Dollar Rises On Higher Oil Prices
The Canadian dollar strengthened against its major counterparts in the European session on Monday, as oil prices rose amid easing worries over a banking crisis and comments from Russian President Vladimir Putin that he will station tactical nuclear weapons in Belarus.
RTTNews
|
885 дней спустя
Canadian Market Modestly Higher; Technology, Financials Shares Move Up
The Canadian market is modestly higher a little before noon on Monday, led by gains in technology, financials, energy and consumer staples sections.
RTTNews
|
885 дней спустя
Dollar Retreats As Banking Crisis Weakens Fed's Inflation Combat
The banking crisis that erupted over the past fortnight or more in the U.S. continued to disrupt currency market equations globally in the week ended March 24.
RTTNews
|
885 дней спустя
PRA Group Appoints Vikram Atal To Succeed Kevin Stevenson As President And CEO
PRA Group, Inc. (PRAA) announced Monday that its board of directors has elected longtime board member Vikram Atal as its president and CEO, effective immediately. Atal replaces Kevin Stevenson, who has served as president and CEO since 2017 and is leaving the company.
RTTNews
|
885 дней спустя
more news
Saudi National Bank Chair Al Khudairy Resigns After His Comments On Credit Suisse
The chairman of Saudi National Bank, Ammar Al Khudairy, has resigned days after he commented about Credit Suisse Group AG that allegedly sent the Swiss bank's stock into a tailspin, ending in its subsequent takeover by domestic rival UBS Group. In a statement, Saudi National Bank or SNB, Credit Suisse's largest shareholder, said it has appointed Chief Executive Officer Saeed Mohammed Al Ghamdi...
RTTNews
|
885 дней спустя
Eurozone Bank Lending Growth Weakens In February
Eurozone bank lending to the private sector registered a slower growth in February reflecting weak credit demand amid higher interest rates and subdued economic activity, data from the European Central Bank revealed Monday. The annual growth rate of credit to the private sector slowed to 3.3 percent in February, the slowest since August 2021, from 3.8 percent in January.
RTTNews
|
885 дней спустя
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
885 дней спустя
Bay Street Looks Set To Open On Firm Note
Higher Canadian and U.S. futures, and firm crude oil prices point to a positive start for the Canadian market on Monday.
RTTNews
|
885 дней спустя
Codiak BioSciences Voluntarily Files For Bankruptcy Protection
Biopharmaceutical company Codiak BioSciences, Inc. (CDAK) announced Monday that it has voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and will seek to pursue a sale process for its assets which is intended to maximize the value of the Company.
RTTNews
|
885 дней спустя
Cyclerion Gets FDA Orphan Drug Designation For Zagociguat For Mitochondrial Diseases
Biopharmaceutical company Cyclerion Therapeutics, Inc. (CYCN) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to zagociguat (previously CY6463) for the treatment of mitochondrial diseases.
RTTNews
|
885 дней спустя
Stay up to date!
Add Новости to your browser
Add To Chrome
